SCHEMBL20143867

SCHEMBL20143867

CCOC(=O)c1ccc2[nH]c(Cc3c[nH]c4ccccc34)cc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.59
GPR84 Q9NQS5 1/20 0.57
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MAPT P10636 2/20 0.56
HCRTR1 O43613 2/20 0.56
RAB9A P51151 1/20 0.56
PCSK9 Q8NBP7 4/20 0.56
PKM P14618 1/20 0.51
TP53 P04637 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523176 0.85 PCSK9 (0.62) AHRGPR84ALDH1A1SMN1; SMN2MEN1
SCHEMBL21985665 0.79 KDM4E (0.47) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL12852233 0.79 KDM4E (0.62) GPR84ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29654185 0.76 HRH3 (0.59) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL20465141 0.76 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL20143872 0.76 AHR (0.82) AHRGPR84ALDH1A1SMN1; SMN2MEN1
SCHEMBL7474003 0.76 HRH3 (0.60) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL29886525 0.76 AHR (1.00) AHRGPR84MEN1KMT2AMAPT
SCHEMBL12852216 0.76 AHR (1.00) AHRGPR84MEN1KMT2AMAPT
SCHEMBL27650006 0.75 HSD17B10 (0.66) GPR84ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10730833-B2 Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2020-08-04 US disclosed
US-20180222861-A1 SYNTHESIS OF DIINDOLYLMETHANES AND INDOLO[3,2-B]CARBAZOLES, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-08-09 US disclosed
US-9969686-B2 Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730833-B2 Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them GLP1R, GIPR, INSR AHR 23/4885GPR84 413/4885ALDH1A1 4327/4885
US-20180222861-A1 SYNTHESIS OF DIINDOLYLMETHANES AND INDOLO[3,2-B]CARBAZOLES, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLP1R, GIPR, INSR AHR 23/4885GPR84 413/4885ALDH1A1 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.